This reduction in DPP-IV activity is observed for all RA patients groups including the No BT group (milder cases) but a significant reduction in sCD26 is observed only for RA patients treated with anti-CD20 (Table 4). The gene discussed is DPP4; the disease is rheumatoid arthritis.